Close

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies.

Continue Find out more

17 Aug 2010
Director/PDMR Shareholding

August 17, 2010 - Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company (the “Company”), announces that on August 17, 2010, it was notified by Ms Barbara Deptula, a Person Discharging Managerial Responsibility, of the exercise, on August 16, 2010, of Stock Appreciation Rights over 13,334 Shire American Depositary Shares (“ADSs”) at an exercise price of $49.36, resulting in 3,795 ADSs being released.

The Company was also notified by Ms Deptula on August 17, 2010 of the following sale of ADSs and Shire plc ordinary shares of 5p each (“Shares”).

Date of SaleNumber of ADSs soldNumber of Shares soldSale Price
    
August 16, 20103,795-$69.00
August 13, 201013,317-$68.816
August 13, 20101,300-$68.910
August 13, 20102,437-$68.76
August 13, 2010-21,617£14.767573


Following the above transactions, Ms Deptula holds awards of Stock Appreciation Rights, Performance Shares and Restricted Shares over 81,797 ADSs. One ADS equals 3 Shares.

This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a) of the Disclosure

Tony Guthrie
Deputy Company Secretary

 

For further information please contact:

Investor Relations  
   
Eric Rojaserojas@shire.com+1 781 482 0999

 

Notes to editors

SHIRE PLC

Shire’s strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions.  Shire’s in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights.  Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company’s website: www.shire.com.

17 Aug 2010 Director/PDMR Shareholding (18KB PDF)

« Back to Shire news

Did you know...

You can sign up to receive email and SMS alerts so that you can keep up to speed with our latest news.

Email and SMS alerts

Did you know...

We donated over $35,000 in
outdated laboratory
equipment
to local
schools?